首页|某院肺炎克雷伯菌感染特点及耐药性分析

某院肺炎克雷伯菌感染特点及耐药性分析

扫码查看
目的 探讨2015-2021年清镇市第一人民医院肺炎克雷伯菌感染特点及耐药性变化情况,为控制肺炎克雷伯菌感染及合理用药提供参考依据.方法 通过法国梅里埃Vitek-2 Compact全自动微生物分析系统进行肺炎克雷伯菌的鉴定和药物敏感性试验,按照美国临床实验室标准化研究所(CLSI)的标准判断结果,采用Whonet 5.6和SPSS 25.0软件统计分析.结果 2015-2021年从各种临床标本中分离得到肺炎克雷伯菌1 486株,其中普通肺炎克雷伯菌(CKP)和高黏液性肺炎克雷伯菌(HMKP)分别占91.5%和8.5%,主要分离自下呼吸道标本(82.2%),来源于儿科(20.4%)、ICU(19.3%)、神经外科(15.3%)和呼吸内科(14.9%)病区患者.产超广谱β-内酰胺酶(ESBL)肺炎克雷伯菌和碳青霉烯耐药肺炎克雷伯菌(CRKP)的检出率分别为36.2%和4.1%,产ESBL菌株对多种抗菌药物的耐药率显著高于不产ESBL菌株,CKP分离株耐药率显著高于HMKP分离株(P<0.05),CRKP对β-内酰胺类抗菌药物、喹诺酮类抗菌药物、氨基糖苷类抗菌药物和磺胺类抗菌药物的耐药率均在90.0%以上.结论 2015-2021年清镇市第一人民医院分离肺炎克雷伯菌标本分布特征及耐药性差异较大,对碳青霉烯类抗菌药物耐药性呈上升趋势.CRKP分离株对临床常用抗菌药物耐药严重,临床应依据药敏结果合理选择抗菌药物进行抗感染治疗,并做好CRKP感染患者的消毒隔离措施.
Characteristics and Drug Resistance of Klebsiella pneumoniae Infection in a Hospital
Objective To investigate the characteristics and drug resistance changes of Klebsiella pneumoniae infection in the first People's hospital of Qingzhen City from 2015 to 2021,and to provide reference for the control of Klebsiella pneumoniae infection and rational drug use.Methods The identification and drug sensitivity test of Klebsiella pneumoniae were carried out by the Vitek-2 Compact automatic microbial analysis system in Merieux,France.According to the standards of CLSI,Whonet 5.6 and SPSS 25.0 software were used for statistical analysis.Results During the period of 2015 to 2021,a total of 1486 strains of Klebsiella pneumoniae were isolated from a variety of clinical specimens.Of these,91.5%were common strains(CKP)and 8.5%were hypermucoviscous strains(HMKP),which were primarily isolated from specimens related to the lower respiratory tract(82.2%).Patients from the pediatric(20.4%),intensive care unit(19.3%),neurosurgery(15.3%),and respiratory(14.9%)wards were frequently seen there.The detection rates of super-broad spectrum β-lactamase(ESBL)-producing Klebsiella pneumoniae and carbapenem-resistant Klebsiella pneumoniae(CRKP)were 36.2%and 4.1%,respectively.And,the resistance rate of ESBL producing strains to multiple antibiotics was significantly higher than that of non-ESBL strains,and the resistance rate of CKP isolates was significantly higher than that of HMKP isolates(P<0.05).Furthermore,the drug resistance rate of CRKP to β-lactam antibiotics,quinolones antibiotics,aminoglycosides antibiotics and sulfonamides antibiotics was more than 90.0%.Conclusion Between 2015 and 2021,Klebsiella pneumoniae isolated from the hospital exhibited distinct distribution features and medication resistance,with the latter showing an increasing trend.CRKP isolates are seriously resistant to commonly used clinical antibiotics,and should be rationally selected according to the results of drug sensitivity.Meanwhile,disinfection and isolation measures should be also taken for CRKP infected patients.

Klebsiella pneumoniaehypermucoviscous Klebsiella Pneumoniaecarbapenem-resistant klebsiella pneumoniaeantibacterial drugsdrug resistanceextended-spectrum β-lactamases

陈敏、赵德军

展开 >

清镇市第一人民医院,贵州清镇 551400

肺炎克雷伯菌 高黏液性肺炎克雷伯菌 碳青霉烯耐药肺炎克雷伯菌 抗菌药物 耐药性 超广谱β-内酰胺酶

2024

国外医药(抗生素分册)
中国医药集团总公司四川抗菌素工业研究所,中国医学科学院医药生物技术研究所

国外医药(抗生素分册)

影响因子:0.852
ISSN:1001-8751
年,卷(期):2024.45(3)
  • 25